Surrozen Inc (SRZN : NASDAQ)
Common Stock
$33.68
USD
+17.52 (108.42%)
Last updated: 2026-09-24
Follow SRZN
SRZN
Surrozen Inc
WealthAwesomePerformance
1 Day
+108.42%
1 Week
+98.82%
1 Month
+44.18%
YTD
+40.10%
Key Statistics
Market Cap
$189.94M
52W High
$35.86
52W Low
$11.39
P/E Ratio
-
50 Day MA
$21.46
200 Day MA
$24.25
Beta
0.56
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/24/2026 | $30.56 | $35.86 | $29.10 | $33.68 | $33.68 | 11,526,993 |
| 9/23/2026 | $17.54 | $17.54 | $16.14 | $16.16 | $16.16 | 115,520 |
| 9/22/2026 | $16.78 | $17.60 | $16.56 | $17.60 | $17.60 | 89,808 |
| 9/21/2026 | $16.74 | $17.45 | $16.44 | $16.53 | $16.53 | 129,007 |
| 9/18/2026 | $16.97 | $17.68 | $16.43 | $16.55 | $16.55 | 190,200 |
| 9/17/2026 | $17.27 | $17.48 | $16.44 | $16.94 | $16.94 | 268,456 |
| 9/16/2026 | $17.84 | $17.86 | $16.78 | $16.93 | $16.93 | 116,635 |
| 9/15/2026 | $17.81 | $18.34 | $17.15 | $17.77 | $17.77 | 151,943 |
| 9/14/2026 | $19.03 | $19.29 | $17.61 | $17.84 | $17.84 | 198,202 |
| 9/11/2026 | $19.68 | $19.72 | $18.71 | $19.00 | $19.00 | 145,344 |
Analyst Price Targets
Based on 2 analysts covering SRZN · as of Sep 17, 2026
Wall Street analysts forecast SRZN stock price to rise 33.0% over the next 12 months.
Consensus
Strong Buy4.50 / 5.00
Avg. Target
US$44.80
+33.0% Upside
Current Price
US$33.68
Last close
Analyst Breakdown (2 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SRZN's historical volatility
30-Day Vol
223.2%
Annualized
90-Day Vol
155.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$40.26
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$35.75 | US$16.55 – US$77.22 |
| 60 trading days | US$37.94 | US$12.77 – US$112.75 |
| 90 trading days | US$40.26 | US$10.61 – US$152.85 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Surrozen Inc
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Financials
- Revenue (TTM)
- $11.51M
- EBITDA
- $-44.13M
- Profit Margin
- 0.00%
- ROE (TTM)
- -62.80%
- EPS (Diluted)
- -40.06
- Book Value
- -18.60
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About SRZN.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RPGL | Republic Power Group Limited Class A Ordinary Shares | $14.69 | +1363.23% |
| KITT | Nauticus Robotics Inc. | $2.93 | +459.21% |
| ZWZZT | NASDAQ TEST STOCK | $24.50 | +144.51% |
| GLND | Greenland Energy Company Common Stock | $5.35 | +83.85% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.65 | +80.62% |
| STAK | STAK Inc. Ordinary Shares | $1.44 | +53.19% |
| PFSA | Profusa, Inc. Common Stock | $3.03 | +47.80% |
| YDES | YD Bio Ltd | $4.77 | +47.68% |